Coagulation status in patients with coronary artery disease taking 100 mg aspirin and healthy volunteers using

M Feuring1, M Wehling, A Ruf

  • 1Institute of Experimental and Clinical Pharmacology and Toxicology, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.

Insights

Age increases blood clot risk. Elderly individuals and those with coronary artery disease show higher coagulability compared to young adults, as measured by rotation thrombelastography (ROTEM®).

Area of Science:

  • Hematology
  • Gerontology
  • Cardiovascular Medicine

Background:

  • Age is a significant risk factor for thromboembolic events.
  • Previous studies indicated increased procoagulant activity in elderly patients with coronary artery disease using thrombelastography.
  • Understanding age-related coagulation differences is crucial for cardiovascular health.

Purpose of the Study:

  • To investigate age-related differences in coagulation status.
  • To compare coagulation parameters in patients with coronary artery disease, healthy elderly, and healthy young volunteers.
  • To utilize rotation thrombelastography (ROTEM®) and PFA-100® for detailed analysis.

Main Methods:

  • Employed rotation thrombelastography (ROTEM®) and PFA-100® assays.
  • Assessed clot formation time (CFT) and maximum clot formation (MCF) using ROTEM® (EXTEM).
  • Evaluated closure times using the collagen/epinephrine cartridge of the PFA-100®.

Main Results:

  • Healthy young volunteers exhibited significantly longer clot formation times (CFT) and lower maximum clot formation (MCF) compared to healthy elderly and coronary artery disease patients.
  • No significant difference in CFT or MCF was observed between healthy elderly individuals and patients with coronary artery disease.
  • PFA-100® showed a trend towards longer closure times in young volunteers, but differences were not statistically significant.

Conclusions:

  • Findings indicate age-related variations in thrombelastographic parameters.
  • ROTEM® analysis suggests increased blood coagulability in both healthy elderly individuals and patients with coronary artery disease compared to younger adults.
  • These results highlight the impact of aging and cardiovascular disease on hemostasis.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...